Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
0(0%)
Results Posted
25%(1 trials)
Terminated
1(14%)

Phase Distribution

Ph phase_3
2
29%
Ph early_phase_1
1
14%
Ph not_applicable
4
57%

Phase Distribution

1

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution7 total trials
Early Phase 1First-in-human
1(14.3%)
Phase 3Large-scale testing
2(28.6%)
N/ANon-phased studies
4(57.1%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

66.7%

4 of 6 finished

Non-Completion Rate

33.3%

2 ended early

Currently Active

0

trials recruiting

Total Trials

7

all time

Status Distribution
Completed(4)
Terminated(2)
Other(1)

Detailed Status

Completed4
unknown1
Withdrawn1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
0
Success Rate
80.0%
Most Advanced
Phase 3

Trials by Phase

Early Phase 11 (14.3%)
Phase 32 (28.6%)
N/A4 (57.1%)

Trials by Status

unknown114%
withdrawn114%
completed457%
terminated114%

Recent Activity

Clinical Trials (7)

Drug Details

Intervention Type
OTHER
Total Trials
7